Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

Prospective Study of Isolated Recurrent Tumor Re-irradiation With Carbon-Ion Beams.

Shirai K, Ohno T, Saitoh JI, Okamoto M, Katoh H, Murata K, Kawamura H, Musha A, Abe T, Mizukami T, Akahane K, Nakano T.

Front Oncol. 2019 Mar 27;9:181. doi: 10.3389/fonc.2019.00181. eCollection 2019.

2.

Successful hematopoietic stem cell transplantation from an HLA-mismatched parent for engraftment failure after unrelated cord blood transplantation in patients with juvenile myelomonocytic leukemia: Report of two cases.

Akahane K, Watanabe A, Furuichi Y, Somazu S, Oshiro H, Goi K, Sakashita K, Muramatsu H, Hama A, Takahashi Y, Koike K, Kojima S, Sugita K, Inukai T.

Pediatr Transplant. 2019 Feb 20:e13378. doi: 10.1111/petr.13378. [Epub ahead of print]

PMID:
30786117
3.

Damage to sebaceous gland and the efficacy of moisturizer after whole breast radiotherapy: a randomized controlled trial.

Ogita M, Sekiguchi K, Akahane K, Ito R, Haga C, Arai S, Ishida Y, Kawamori J.

BMC Cancer. 2019 Feb 7;19(1):125. doi: 10.1186/s12885-019-5334-9.

4.

Eradication of Central Nervous System Leukemia of T-Cell Origin with a Brain-Permeable LSD1 Inhibitor.

Saito S, Kikuchi J, Koyama D, Sato S, Koyama H, Osada N, Kuroda Y, Akahane K, Inukai T, Umehara T, Furukawa Y.

Clin Cancer Res. 2019 Mar 1;25(5):1601-1611. doi: 10.1158/1078-0432.CCR-18-0919. Epub 2018 Dec 5.

PMID:
30518632
5.

Results of a nationwide survey on Japanese clinical practice in breast-conserving radiotherapy for breast cancer.

Aibe N, Karasawa K, Aoki M, Akahane K, Ogawa Y, Ogo E, Kanamori S, Kawamori J, Saito AI, Shiraishi K, Sekine H, Tachiiri S, Yoshimura M, Yamauchi C.

J Radiat Res. 2019 Jan 1;60(1):142-149. doi: 10.1093/jrr/rry095.

6.

[Inaugural Message from the President of JSMP].

Akahane K.

Igaku Butsuri. 2018;38(1):1. doi: 10.11323/jjmp.38.1_1. Japanese. No abstract available.

7.

[Survey of Recognition, Utilization, and Evaluation for Diagnostic Reference Levels in the Field of X-ray Computed Tomography].

Matsubara K, Matsunaga Y, Yanagawa N, Muramatsu Y, Ida Y, Suzuki S, Akahane K, Ishiguchi T.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018;74(7):700-707. doi: 10.6009/jjrt.2018_JSRT_74.7.700. Japanese.

8.

VALIDATION OF MONTE CARLO DOSE CALCULATION FOR PAEDIATRIC CT EXAMINATIONS USING TUBE CURRENT MODULATION BASED ON IN-PHANTOM DOSIMETRY.

Fujii K, Nomura K, Muramatsu Y, Obara S, Goto T, Akahane K, Ota H, Tsukagoshi S, Kusumoto M.

Radiat Prot Dosimetry. 2018 Dec 1;182(4):508-517. doi: 10.1093/rpd/ncy109.

PMID:
30032259
9.

T315I mutation of BCR-ABL1 into human Philadelphia chromosome-positive leukemia cell lines by homologous recombination using the CRISPR/Cas9 system.

Tamai M, Inukai T, Kojika S, Abe M, Kagami K, Harama D, Shinohara T, Watanabe A, Oshiro H, Akahane K, Goi K, Sugihara E, Nakada S, Sugita K.

Sci Rep. 2018 Jul 2;8(1):9966. doi: 10.1038/s41598-018-27767-6.

10.

Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy with a passive beam: Organ doses in prostate cancer treatment.

Yonai S, Matsufuji N, Akahane K.

Phys Med. 2018 Jul;51:48-55. doi: 10.1016/j.ejmp.2018.04.391. Epub 2018 Apr 24.

PMID:
29699921
11.

Efficacy of heparinoid moisturizer as a prophylactic agent for radiation dermatitis following radiotherapy after breast-conserving surgery: a randomized controlled trial.

Sekiguchi K, Akahane K, Ogita M, Haga C, Ito R, Arai S, Ishida Y, Tsukada Y, Kawamori J.

Jpn J Clin Oncol. 2018 May 1;48(5):450-457. doi: 10.1093/jjco/hyy045.

12.

Water-like anomalies as a function of tetrahedrality.

Russo J, Akahane K, Tanaka H.

Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3333-E3341. doi: 10.1073/pnas.1722339115. Epub 2018 Mar 26.

13.

Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.

Huang M, Inukai T, Miyake K, Tanaka Y, Kagami K, Abe M, Goto H, Minegishi M, Iwamoto S, Sugihara E, Watanabe A, Somazu S, Shinohara T, Oshiro H, Akahane K, Goi K, Sugita K.

Cancer Med. 2018 Apr;7(4):1297-1316. doi: 10.1002/cam4.1323. Epub 2018 Feb 23.

14.

AUTOMATIC ACQUISITION OF CT RADIATION DOSE DATA: USING THE DIAGNOSTIC REFERENCE LEVEL FOR RADIATION DOSE OPTIMIZATION.

Nakada Y, Okuda Y, Tsuge T, Suzuki J, Sakamoto H, Yamamoto T, Konishi Y, Tsujimoto T, Nishiki S, Satoh T, Aoyama N, Morimoto K, Aita M, Yamashita Y, Yoshitake T, Mukai M, Yokooka Y, Yokohama N, Akahane K.

Radiat Prot Dosimetry. 2018 Oct 1;181(2):156-167. doi: 10.1093/rpd/ncy003.

PMID:
29425381
15.

Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines.

Takahashi K, Inukai T, Imamura T, Yano M, Tomoyasu C, Lucas DM, Nemoto A, Sato H, Huang M, Abe M, Kagami K, Shinohara T, Watanabe A, Somazu S, Oshiro H, Akahane K, Goi K, Kikuchi J, Furukawa Y, Goto H, Minegishi M, Iwamoto S, Sugita K.

PLoS One. 2017 Dec 13;12(12):e0188680. doi: 10.1371/journal.pone.0188680. eCollection 2017.

16.

Autologous Stem Cell Rescue for Graft Failure of Second Allogeneic Stem Cell Transplant After Engraftment of Primary Allogeneic Transplant.

Watanabe A, Inukai T, Akahane K, Somazu S, Oshiro H, Goi K, Koizumi K, Harii N, Matsuda K, Sugita K.

Exp Clin Transplant. 2019 Apr;17(2):281-283. doi: 10.6002/ect.2016.0315. Epub 2017 Jul 31.

17.

Effects of combination of mitiglinide with various oral antidiabetic drugs in streptozotocin-nicotinamide-induced type 2 diabetic rats and Zucker fatty rats.

Akahane K, Ojima K, Yokoyama A, Inoue T, Kiguchi S, Tatemichi S, Takeda H, Imai Y.

Clin Exp Pharmacol Physiol. 2017 Dec;44(12):1263-1271. doi: 10.1111/1440-1681.12823. Epub 2017 Sep 5.

PMID:
28744906
18.

2. Current Status of DRLs in the World.

Akahane K.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73(6):469-476. doi: 10.6009/jjrt.2017_JSRT_73.6.469. Japanese. No abstract available.

19.

Representativeness of individual external doses estimated for one quarter of residents in the Fukushima Prefecture after the nuclear disaster: the Fukushima Health Management Survey.

Ishikawa T, Takahashi H, Yasumura S, Ohtsuru A, Sakai A, Ohira T, Sakata R, Ozasa K, Akahane K, Yonai S, Kurihara O, Kamiya K, Abe M.

J Radiol Prot. 2017 Sep 25;37(3):584-605. doi: 10.1088/1361-6498/aa6649. Epub 2017 Jun 15.

PMID:
28617669
20.

Report of IRPA task group on the impact of the eye lens dose limits.

Cantone MC, Ginjaume M, Miljanic S, Martin CJ, Akahane K, Mpete L, Michelin SC, Flannery CM, Dauer LT, Balter S.

J Radiol Prot. 2017 Jun 26;37(2):527-550. doi: 10.1088/1361-6498/aa604b. Epub 2017 Jun 6.

21.

Current situations and discussions in Japan in relation to the new occupational equivalent dose limit for the lens of the eye.

Yokoyama S, Hamada N, Hayashida T, Tsujimura N, Tatsuzaki H, Kurosawa T, Nabatame K, Ohguchi H, Ohno K, Yamauchi-Kawaura C, Iimoto T, Ichiji T, Hotta Y, Iwai S, Akahane K.

J Radiol Prot. 2017 Sep 25;37(3):659-683. doi: 10.1088/1361-6498/aa73e8. Epub 2017 May 18.

PMID:
28516892
22.

Comparison of the Effects of Mitiglinide and Glibenclamide Administered in Combination with the Dipeptidyl Peptidase-IV Inhibitor Sitagliptin in Rats with Streptozotocin-Nicotinamide-Induced Type 2 Diabetes.

Akahane K, Ojima K, Yokoyama A, Inoue T, Kiguchi S, Tatemichi S, Takeda H, Kobayashi M.

Drug Res (Stuttg). 2017 Jul;67(7):396-403. doi: 10.1055/s-0043-102951. Epub 2017 May 9.

PMID:
28486736
23.

Anti-leukaemic activity of the TYK2 selective inhibitor NDI-031301 in T-cell acute lymphoblastic leukaemia.

Akahane K, Li Z, Etchin J, Berezovskaya A, Gjini E, Masse CE, Miao W, Rocnik J, Kapeller R, Greenwood JR, Tiv H, Sanda T, Weinstock DM, Look AT.

Br J Haematol. 2017 Apr;177(2):271-282. doi: 10.1111/bjh.14563. Epub 2017 Mar 14.

24.

Effects of non-exciton components excited by broadband pulses on quantum beats in a GaAs/AlAs multiple quantum well.

Kojima O, Iwasaki Y, Kita T, Akahane K.

Sci Rep. 2017 Jan 27;7:41496. doi: 10.1038/srep41496.

25.

Haploidentical hematopoietic cell transplantation for disseminated Ewing sarcoma.

Yoshihara H, Kumamoto T, Ono R, Akahane K, Nozaki T, Kobayashi S, Kikuta A, Matsumoto S, Hasegawa D, Ogawa C, Manabe A.

Pediatr Int. 2017 Feb;59(2):223-226. doi: 10.1111/ped.13195. Epub 2016 Dec 27.

PMID:
28026886
26.

Reconstruction of Internal and External Exposures of Fukushima Residents.

Akahane K.

Radiat Prot Dosimetry. 2016 Sep;171(1):3-6. doi: 10.1093/rpd/ncw186.

PMID:
27664996
27.

A possible four-phase coexistence in a single-component system.

Akahane K, Russo J, Tanaka H.

Nat Commun. 2016 Aug 25;7:12599. doi: 10.1038/ncomms12599.

28.

Erythrophagocytosis in T-cell type acute lymphoblastic leukaemia with near-tetraploidy.

Watanabe A, Akahane K, Somazu S, Oshiro H, Goi K, Miyachi H, Kiyokawa N, Inukai T, Sugita K.

J Clin Pathol. 2016 Dec;69(12):1129-1132. doi: 10.1136/jclinpath-2016-203915. Epub 2016 Aug 12. No abstract available.

PMID:
27520437
29.

Organ Dose Evaluations Based on Monte Carlo Simulation for CT Examinations Using Tube Current Modulation.

Fujii K, Nomura K, Muramatsu Y, Obara S, Akahane K, Kusumoto M.

Radiat Prot Dosimetry. 2017 Apr 28;174(3):387-394. doi: 10.1093/rpd/ncw144.

PMID:
27342451
30.

Synergy between loss of NF1 and overexpression of MYCN in neuroblastoma is mediated by the GAP-related domain.

He S, Mansour MR, Zimmerman MW, Ki DH, Layden HM, Akahane K, Gjini E, de Groh ED, Perez-Atayde AR, Zhu S, Epstein JA, Look AT.

Elife. 2016 Apr 27;5. pii: e14713. doi: 10.7554/eLife.14713.

31.

An influential factor for external radiation dose estimation for residents after the Fukushima Daiichi Nuclear Power Plant accident-time spent outdoors for residents in Iitate Village.

Ishikawa T, Yasumura S, Ohtsuru A, Sakai A, Akahane K, Yonai S, Sakata R, Ozasa K, Hayashi M, Ohira T, Kamiya K, Abe M.

J Radiol Prot. 2016 Jun;36(2):255-68. doi: 10.1088/0952-4746/36/2/255. Epub 2016 Apr 1.

PMID:
27034103
32.

Diagnostic Reference Levels: DRLs.

Akahane K.

Igaku Butsuri. 2016;36(2):121-125. doi: 10.11323/jjmp.36.2_121. Japanese. No abstract available.

33.

Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome-Positive Lymphoid Leukemia.

Nemoto A, Saida S, Kato I, Kikuchi J, Furukawa Y, Maeda Y, Akahane K, Honna-Oshiro H, Goi K, Kagami K, Kimura S, Sato Y, Okabe S, Niwa A, Watanabe K, Nakahata T, Heike T, Sugita K, Inukai T.

Mol Cancer Ther. 2016 Jan;15(1):94-105. doi: 10.1158/1535-7163.MCT-14-1065. Epub 2015 Dec 4.

34.
35.

Nationwide survey of radiation exposure during pediatric computed tomography examinations and proposal of age-based diagnostic reference levels for Japan.

Takei Y, Miyazaki O, Matsubara K, Shimada Y, Muramatsu Y, Akahane K, Fujii K, Suzuki S, Koshida K.

Pediatr Radiol. 2016 Feb;46(2):280-5.

PMID:
26494635
36.

Randomized, prospective assessment of moisturizer efficacy for the treatment of radiation dermatitis following radiotherapy after breast-conserving surgery.

Sekiguchi K, Ogita M, Akahane K, Haga C, Ito R, Arai S, Ishida Y, Tsukada Y, Kawamori J.

Jpn J Clin Oncol. 2015 Dec;45(12):1146-53. doi: 10.1093/jjco/hyv155. Epub 2015 Oct 20.

37.

DEVELOPMENT OF AGE-SPECIFIC JAPANESE PHYSICAL PHANTOMS FOR DOSE EVALUATION IN INFANT CT EXAMINATIONS.

Yamauchi-Kawaura C, Fujii K, Akahane K, Yamauchi M, Obara S, Narai K, Katsu T, Imai K, Ikeda M.

Radiat Prot Dosimetry. 2016 Dec;171(4):483-502. Epub 2015 Sep 28.

PMID:
26420904
38.

[Estimation of Maximum Entrance Skin Dose during Cerebral Angiography].

Kawauchi S, Moritake T, Hayakawa M, Hamada Y, Sakuma H, Yoda S, Satoh M, Sun L, Koguchi Y, Akahane K, Chida K, Matsumaru Y.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2015 Sep;71(9):746-57. doi: 10.6009/jjrt.2015_JSRT_71.9.746. Japanese.

39.

Estimation of Organ and Effective Doses for Neonate and Infant Diagnostic Cardiac Catheterizations.

Kawasaki T, Fujii K, Akahane K.

AJR Am J Roentgenol. 2015 Sep;205(3):599-603. doi: 10.2214/AJR.14.13852.

PMID:
26295648
40.

HSP90 inhibition leads to degradation of the TYK2 kinase and apoptotic cell death in T-cell acute lymphoblastic leukemia.

Akahane K, Sanda T, Mansour MR, Radimerski T, DeAngelo DJ, Weinstock DM, Look AT.

Leukemia. 2016 Jan;30(1):219-28. doi: 10.1038/leu.2015.222. Epub 2015 Aug 12.

41.

Development of Selective Covalent Janus Kinase 3 Inhibitors.

Tan L, Akahane K, McNally R, Reyskens KM, Ficarro SB, Liu S, Herter-Sprie GS, Koyama S, Pattison MJ, Labella K, Johannessen L, Akbay EA, Wong KK, Frank DA, Marto JA, Look TA, Arthur JS, Eck MJ, Gray NS.

J Med Chem. 2015 Aug 27;58(16):6589-606. doi: 10.1021/acs.jmedchem.5b00710. Epub 2015 Aug 18.

42.

The Fukushima Health Management Survey: estimation of external doses to residents in Fukushima Prefecture.

Ishikawa T, Yasumura S, Ozasa K, Kobashi G, Yasuda H, Miyazaki M, Akahane K, Yonai S, Ohtsuru A, Sakai A, Sakata R, Kamiya K, Abe M.

Sci Rep. 2015 Aug 4;5:12712. doi: 10.1038/srep12712.

43.

Estimating Annual Individual Doses for Evacuees Returning Home to Areas Affected by the Fukushima Nuclear Accident.

Yajima K, Kurihara O, Ohmachi Y, Takada M, Omori Y, Akahane K, Kim E, Torikoshi M, Yonehara H, Yoshida S, Sakai K, Akashi M.

Health Phys. 2015 Aug;109(2):122-33. doi: 10.1097/HP.0000000000000308.

PMID:
26107433
44.

Effective eculizumab therapy followed by BMT in a boy with paroxysmal nocturnal hemoglobinuria.

Oshiro H, Goi K, Akahane K, Inukai T, Sugita K.

Pediatr Int. 2015 Apr;57(2):e27-9. doi: 10.1111/ped.12522.

PMID:
25868955
45.

Evaluation of organ doses in adult and paediatric CT examinations based on Monte Carlo simulations and in-phantom dosimetry.

Fujii K, Nomura K, Muramatsu Y, Takahashi K, Obara S, Akahane K, Satake M.

Radiat Prot Dosimetry. 2015 Jul;165(1-4):166-71. doi: 10.1093/rpd/ncv074. Epub 2015 Apr 5.

PMID:
25848103
46.

Estimation of organ doses and effective doses in image-guided respiration-gated radiotherapy.

Nakao M, Obara S, Nabatame K, Akahane K, Sanada S, Shirai T.

Radiat Prot Dosimetry. 2016 Jan;168(1):83-91. doi: 10.1093/rpd/ncv015. Epub 2015 Apr 5.

PMID:
25848094
47.

An awareness survey of surgeons involved in breast cancer treatment regarding their patients returning to work.

Akahane K, Tsunoda N, Murata T, Fujii M, Fuwa Y, Wada K, Oda K, Nagino M.

Nagoya J Med Sci. 2014 Aug;76(3-4):315-22.

48.

Optimised paediatric CT dose at a tertiary children's hospital in Japan: a 4-y single-centre analysis.

Nakada Y, Fujiwara M, Yakami M, Yokoyama T, Shirayama A, Yamamoto H, Nabatame K, Obara S, Akahane K, Blyth BJ, Miyazaki O, Date H, Yagi K, Hoshioka A, Shimada Y.

Radiat Prot Dosimetry. 2016 Jan;168(1):61-71. doi: 10.1093/rpd/ncv004. Epub 2015 Feb 10.

PMID:
25669653
49.

Simultaneous multichannel wavelength multicasting and XOR logic gate multicasting for three DPSK signals based on four-wave mixing in quantum-dot semiconductor optical amplifier.

Qin J, Lu GW, Sakamoto T, Akahane K, Yamamoto N, Wang D, Wang C, Wang H, Zhang M, Kawanishi T, Ji Y.

Opt Express. 2014 Dec 1;22(24):29413-23. doi: 10.1364/OE.22.029413.

PMID:
25606876
50.

Factors that delay treatment of symptomatic metastatic extradural spinal cord compression.

Tsukada Y, Nakamura N, Ohde S, Akahane K, Sekiguchi K, Terahara A.

J Palliat Med. 2015 Feb;18(2):107-13. doi: 10.1089/jpm.2014.0099. Epub 2014 Oct 24.

PMID:
25343305

Supplemental Content

Loading ...
Support Center